Skip to content

Comparative outcomes of proton vs photon radiation therapy

Protons Versus Photons In Craniospinal Axis Irradiation (Picasso): A Phase 3 Randomized Controlled Trial - PICASSO

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097548
Enrollment
150
Registered
2025-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G938- Other specified disorders of brain

Interventions

Intervention1: Proton beam therapy: Patients in the test arm (proton beam therapy) will receive CSI plus TB boost to appropriate cobalt gray dose equivalent (CGE) on a modern proton gantry using image

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosis of primary CNS tumor planned for craniospinal irradiation. Curative-intent CSI with or without systemic chemotherapy. Age at irradiation: more than 5 years to 39 years. Fair performance status (LPS/KPS): greater equal to 60. Written informed consent/assent.

Exclusion criteria

Exclusion criteria: Reirradiation Palliative intent radiation On concurrent medications likely to impact neurocognitive outcomes Inability to undergo neurocognitive evaluation pre-radiation.

Design outcomes

Primary

MeasureTime frame
2-year Qualified Overall Survival (QOS)Timepoint: 2 yrs

Secondary

MeasureTime frame
Neuro-cognitive outcome: FSIQ, Verbal comprehension, Perceptual Reasoning Neuro-endocrine outcomes: Hormonal profile Visual outcomes: Drop in acuity or new-onset field defects Hearing outcomes: Chang-Brock scale Symptomatic radiation necrosis (requiring bevacizumab) Patterns of failure/relapse Vasculopathy including cerebrovascular accidents (CVA) Second malignant neoplasm (SMN)Timepoint: Baseline,6 months post RT,1yr,2yr,3yr,4yr,5yr;5-year progression-free survival (PFS) 5-year overall survival (OS) 5-year QOSTimepoint: 5 years

Countries

India

Contacts

Public ContactDr Tejpal Gupta

Tata Memorial Centre

tejpalgupta@rediffmail.com02224177000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026